Others

Trident Texofab Ltd - Outcome of Board Meeting

| Updated on March 30, 2019 Published on March 30, 2019

Trident Texofab Limited has informed that the board of directors of the company has approved revised Code of Practices and Procedures for fair disclosure of Unpublished price sensitive information to be effective from April 01st, 2019 to align it with SEBI(Prohibition of Insider Trading)(Amendment) Regulation,2018.

This is for your information and records.

Pdf Link: Trident Texofab Ltd - Outcome of Board Meeting

Source : BSE - www.bseindia.com

Published on March 30, 2019
This article is closed for comments.
Please Email the Editor